From: Becker's GI & Endoscopy <editorial@beckershealthcare.com>
Subject: EndoChoice, AbbVie & more: 5 GI company updates | Keeping up with MU in GI | 12 healthcare leaders on the PPACA, physicians & more
Reply: editorial@beckershealthcare.com
View our profile on LinkedIn Follow us on Twitter Like us on Facebook Find us on Google+ 


November 18, 2014
Today's Top Stories
1. How to keep up with meaningful use requirements in GI     Full story

2. EndoChoice FDA clearance, AbbVie's HCV drug cures 97% & more - 5 recent GI/endoscopy company key notes Full story
 
3. Complimentary webinar: The secret to bringing more orthopedic and spine cases into ASCs: With a special focus on total hips and knees Register Here
 
4. Becker's CEO roundtable: 12 healthcare leaders on their priorities, the PPACA and physicians  Full story

5. Jersey City Medical Center 1st in New Jersey to offer esophageal cancer prevention procedure Full story

6. How having an opinion changed my career Full story

Ask a gastroenterologist. Next week's question: What are the biggest threats to success in the GI field? Email Carrie Pallardy at cpallardy@beckershealthcare.com to submit a response.
 
13th Annual Spine, Orthopedic and Pain Management-Driven ASC Conference + The Future of Spine 
90+ Physician Leaders to Speak
June 11-13, 2015
To learn more and register, email  registration@beckershealthcare.com
     
  
Channels
Join Our Mailing List
_____________________
Contact Us

Editorial Contact: 
Laura Miller   
Editor in Chief  
(312) 253-9170
email Laura

Sales, Marketing & Events:
Jessica Cole
President and CEO
______________________
 
   
Becker's ASC Review
A Becker's Healthcare Publication
35 E. Wacker Drive, Suite 1782 | Chicago, IL 60601




Copyright 20124. All Rights Reserved.

Forward this email



This email was sent to editorial@beckershealthcare.com by editorial@beckershealthcare.com |  


ASC Communications | 35 E Wacker | Chicago | IL | 60601